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Abstract: 
 
Background: Hepatitis C virus is an important cause of chronic liver disease with 71 million 
people worldwide living with chronic HCV infection as at 2015. Nigeria has the second largest 
burden of HIV in Africa, with 3.2 million Nigerians living with HIV/AIDS in 2016. Most people 
infected with the hepatitis C virus are asymptomatic and often unaware of their infection. This 
study was conducted to determine the prevalence of and risk factors for HCV and HIV infections 
among apparently healthy individuals in Lagos.  
Materials and methods: This was a retrospective study in which the prevalence of hepatitis C 
virus antibodies and HIV was determined among apparently healthy individuals who presented for 
health screening at a private laboratory facility in Lagos from May 2014 to June 2016. The health 
records of those who met the inclusion criteria were systematically reviewed to extract 
demographic and clinical information including age, sex, history of blood transfusion, alcohol use, 
surgery and results of serological tests for antibodies to hepatitis C virus and HIV. 
Results: Out of 1379 apparently healthy individuals included in the study, 60.1% were male. The 
prevalence rate of hepatitis C virus (HCV antibody) and HIV were 0.7% and 2% respectively. 
Hepatitis C virus infection was not significantly associated with history of blood transfusion, alcohol 
use, prior surgery and age. HIV infection was significantly associated with only prior history of 
surgery (OR 4.72, p=0.02).  
Conclusion: In this study of apparently healthy Nigerians, the prevalence rates of HCV and HIV 
were low, no documented HCV-HIV co-infection and surgery was a risk factor for HIV infection. 
Screening of healthy individuals for HIV and HCV infection is very important to determine those 
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Contexte: Le virus de l’hépatite C est une cause importante de maladie hépatique chronique avec 
71 millions de personnes dans le monde vivant avec une infection chronique au VHC en 2015. Le 
Nigéria est le deuxième fardeau du VIH en Afrique, avec 3,2 millions de Nigérians vivant avec le 
VIH/sida en 2016. La plupart des personnes infectées par le virus de l'hépatite C sont 
asymptomatiques et ignorent souvent leur infection. Cette étude visait à déterminer la prévalence 
et les facteurs de risque d'infection par le VHC et le VIH chez des individus apparemment en bonne 
santé à Lagos                                           
Matériels et méthodes: Il s’agit d’une étude rétrospective dans laquelle la prévalence des 
anticorps anti-virus de l’hépatite C et du VIH a été déterminée chez des individus apparemment en 
bonne santé qui se sont présentés pour un dépistage médical dans un laboratoire privé à Lagos de 
mai 2014 à juin 2016. Les dossiers médicaux de ces personnes les personnes répondant aux 
critères d'inclusion ont été systématiquement examinées pour extraire des informations 
démographiques et cliniques, notamment l'âge, le sexe, les antécédents de transfusion sanguine, 
la consommation d'alcool, la chirurgie et les résultats de tests sérologiques pour la recherche 
d'anticorps anti-virus de l'hépatite C et du VIH                   
Résultats: Sur les 1 379 individus apparemment en bonne santé inclus dans l'étude, 60,1% 
étaient des hommes. Le taux de prévalence du virus de l'hépatite C (anticorps anti-VHC) et du VIH 
était respectivement de 0,7% et 2%. L'infection par le virus de l'hépatite C n'était pas associée de 
manière significative aux antécédents de transfusion sanguine, à la consommation d'alcool, à une 
intervention chirurgicale antérieure et à l'âge. L’infection par le VIH était associée de manière 
significative aux antécédents d’opération (OR = 4,72, p = 0,02).                       
Conclusion: Dans cette étude portant sur des Nigérians apparemment en bonne santé, les taux 
de prévalence du VHC et du VIH étaient faibles. Aucune co-infection documentée VHC-VIH et la 
chirurgie ne constituaient un facteur de risque d'infection par le VIH. Le dépistage de l’infection par 
le VIH et le VHC chez les personnes en bonne santé est très important pour déterminer les 
personnes infectées qui ont besoin d’un traitement 




 Hepatitis C virus is a hepatotropic 
virus well known to lead to chronic liver 
disease such as chronic hepatitis, liver 
cirrhosis and hepatocellular carcinoma. 
In 2015, 71 million people were 
estimated to be living with chronic HCV 
infection and the global prevalence of 
HCV was 1% (1). Viral hepatitis was said 
to be responsible for 1.3 million deaths 
in 2015. Worldwide, 2.3 million persons 
living with HIV were also infected with 
hepatitis C virus. The burden of hepatitis 
constitutes a global public threat which 
made the World health assembly in 2016 
to approve a global strategy for the 
elimination of viral hepatitis by the year 
2030 (3). Therefore if people living with 
hepatitis b and hepatitis c infection are 
not diagnosed and treated, the number 
of deaths will continue to rise (1).  
 In 2016, the prevalence rate of 
HIV infection in Nigeria was 2.9% which 
translates into 3.2 million people living 
with HIV/AIDS. There were 220,000 new 
HIV infections and an estimated 160,000 
adult and children died of AIDS (2).  
 
 
 The prevalence of hepatitis C in 
Nigeria from a population based 
screening is 0.9% (4). In Nigeria, its 
prevalence is higher among populations 
at high risk such as patients who are 
positive for the human immuno 
deficiency virus with 2.3% (5), mentally 
ill individuals 12.6% (6), intravenous 
drug users 7.7% (7) and patients with 
sickle cell anaemia 5% (8). 
 Most people with chronic HCV 
infections are asymptomatic and those 
infected most often have no knowledge 
of their infection. Testing for HCV is poor 
as shown in a 2015 study by the World 
health organisation that reported that 
only 20% of those living with HCV 
infection knew their status (1). In 
Nigeria only 34% of people living with 
HIV infection know their status (2). 
Therefore testing for both HIV and HCV 
is very important to know the burden of 
infection and know those who need to 
access care and treatment.  
 One of the strategies for the 
elimination of viral hepatitis is testing 
and treatment. Most of the studies on 
HCV and HIV infection in healthy individuals 
145 
 
hepatitis C in Nigeria have tested few 
individuals and subgroups of the 
population. This study was conducted to 
determine the prevalence and risk 
factors of HCV and HIV among 
apparently healthy individuals in Lagos 
from data collected from a health 
screening programme. 
 
Materials and methods: 
 
Study design 
 This was a retrospective study to 
determine the prevalence of hepatitis C 
virus antibodies and HIV among 
apparently healthy individuals who 
presented for health screening from May 
2014 to June 2016 at a private medical 
diagnostic centre in Lagos. The health 
records of those who met the inclusion 
criteria were systematically reviewed to 
extract the demographic and clinical 
information including age, sex, history of 
blood transfusion, alcohol use, surgery 
and results of serum liver enzymes and 
serological tests for antibodies to 
hepatitis C virus and HIV. The detail of 
the identity of the subjects was kept 
confidential with all identifiers removed 
except for the demographic and clinical 
information mentioned above. 
 The centre is a leading medical 
diagnostic centre in Lagos state. It has a 
health assessment clinic with different 
health check-up plans consisting of a 
range of laboratory and radiological tests 
and clinical examination to detect 
lifestyle diseases early (when chances of 
treatment and cure are better) or 
prevent their occurrence.   
 The eligibility criteria included 
individuals aged 18 years and above 
who registered for health check-up plans 
within the study period that included 
screening tests for Hepatitis C virus 
antibody or HIV. 
Laboratory procedures 
 Antibody to Hepatitis C virus was 
tested on samples collected from the 
clients using the Roche Elecsys HCV 
Antibody (Roche Diagnostics Ltd, 
Mannheim, Germany) assay. This is an 
electrochemiluminescence immunoassay 
“ECLIA” performed on Cobas e 411 
immunoassay analyser. Antibodies to 
Human immunodeficiency virus were 
tested for using the Alere Determine HIV 
1/2 test kit (Alere, USA). The tests were 
done according to manufacturer’s 
instructions. Ethical approval was 
obtained from the Lagos University 
Teaching Hospital Health Research and 
ethics committee.  
 
Data analysis 
 Data was analysed using SPSS 
version 20. Discrete variables were 
analysed using the Chi-square test while 
Student’s t–test was used to evaluate 
differences between means. Odds ratio 
(OR) was used as a measure of the 
strength of association and p value 





Sociodemographic characteristics of 
study participants  
 Out of 1379 apparently healthy 
individuals included in the study, over 
half of them were male (829, 60.1%). Of 
the 1379 participants, 1356 individuals 
were tested for hepatitis C antibody, 
1280 individuals tested for HIV. The 
mean age was 47.1 ± 12 years and 795 
(57.6%) of them were in the age group 
31 – 50 years. There was no significant 
difference between the mean ages of 
male (47.5 ± 11.7 years) and females 
(46.6 ± 12.4 years). Majority (1190, 
87.4%) of the participants were married, 
while 8.8% were single. Most of the 
participants had no history of blood 
transfusion (1318, 95.6%) or prior 
history of surgery (987, 71.6%), see 
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Table 1: Socio-demographic and clinical characteristics of the study participants 
 
Variables Frequency (n = 1379) Percentage (%) 
Gender   
Female 550 39.9 
Male 829 60.1 
Age   
<=30 91 6.6 
31-50 795 57.6 
>50 493 35.8 
Blood Transfusion   
Yes 61 4.4 
No 1318 95.6 
Surgery   
Yes 987 71.6 
No 392 28.4 
Alcohol   
Yes 582 42.2 
No 796 57.8 
Marital status   
Married 1190 87.4 
Single 120 8.8 
Widow 40 2.9 
Separated 8 0.6 
Divorced 3 0.2 
 
 
Prevalence of hepatitis C virus 
 The prevalence of hepatitis C 
virus (HCV antibody) was 0.7% (n=9, 
95% CI 0.3 – 1.1%). The prevalence of 
hepatitis C virus in females was 0.4% 
and 0.9% in males but the difference 
was not statistically significant. The 
mean age of participants who tested 
positive for HCV antibody was 42.6 ± 
12years. The prevalence of HCV 
antibody was highest in the age group 
30 years or younger (1.1%) but the 
difference was not statistically significant 
(p = 0.68).   
 
Risk factors for hepatitis C virus 
infection 
 In the bivariate analysis, 0.7% of 
the married participants tested positive 
for HCV antibody but there was no 
statistical significance between hepatitis 
C virus infection and marital status (p = 
1). Hepatitis C virus infection was not 
significantly associated with history of 
blood transfusion, alcohol use, prior 
surgery and age (p >0.05) (Table 2).  
 
 
Table 2: Risk factors associated with hepatitis C virus infection 
 
Variable Hep C positive 
N (%) 
Hep C negative N (%) P value 
Gender    
Female 2 (0.4) 538  (99.6) 0.33 
Male 7 (0.9) 809  (99.1)  
Age-group    
<=30 1 (1.1) 88 (98.9) 0.68 
31 -50 4 (0.5) 782 (99.5)  
>50 4 (0.8) 477 (99.2)  
Transfusion    
Yes 0 60 (100) 1 
No 9 (0.7) 1287 (99.3)  
Alcohol    
Yes 1 (0.2) 575 (99.8) 0.09 
No 8 (1.0) 771 (99)  
Surgery    
Yes 2 (0.5) 383 (99.5) 0.68 
No 7 (0.7) 964 (99.3)  
Marital status    
Married 8 (0.7) 1160 (99.3) 1.0 
Single 1 (0.8) 118 (99.2)  
Widow/Divorced/Separated 0 51 (100)  
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Table 3: Risk factors associated with HIV infection 
 




OR (CI) P value 
Gender     
Female 6 (1.2) 500(98.8) 1 0.11 
Male 19 (2.5) 755 (97.5) 2.09 (0.83 –5.29)  
Age group     
<30 3 (3.4) 84 (96.6) 3.1(0.73 – 13.22) 0.13 
31-50 17 (2.3) 737 (97.7) 2.0 (0.73 – 5.46) 0.17 
>50 5 (1.1) 434 (98.9) 1  
Transfusion     
Yes 1 (1.8) 54 (98.2) 1 0.94 
No 24 (2) 1201 (98) 1.08 (0.14 – 8.13)  
Alcohol     
Yes 13 (2.4) 537 (97.6) 1.45 (0.65 – 3.19) 0.36 
No 12 (1.7) 717 (98.3) 1  
Surgery     
Yes 2 (0.6) 365 (99.4) 1 0.02 
No 23 (2.5) 890 (97.5) 4.72 (1.11 – 20.11)  
Marital Status     
Married 21 (1.9) 1080 (98.1) 1.13 (0.26 – 4.87) 0.80 
Single 2 (1.7) 116 (98.3) 1  
Widow/Divorced/Separated 2 (4.3) 43 (95.7) 2.7 (0.37 – 19.75) 0.31 
OR = Odd Ratio; CI = Confidence Interval 
 
 
Prevalence of HIV 
 In this study, the prevalence of 
HIV was 2% (n = 25, 95% CI 1.3 – 
2.7%). The prevalence of HIV in females 
was 1.2% and 2.5% in males. The 
difference was not statistically 
significant. The mean age of participants 
who tested positive for HIV was 43.4 ± 
12.4years The prevalence of HIV was 
highest in the age group 30 years or 
younger (3.4%) but the difference was 
not statistically significant (p = 0.24). 
None of the participants was co-infected 
with both HCV and HIV. 
 
Risk factors for HIV infection 
 In the bivariate analysis, HIV 
infection was significantly associated 
with prior history of surgery. Prior 
history of surgery increased the risk of 
HIV infection by 5 times (OR 4.72, 95% 
CI 1.11–20.11, p=0.02). HIV infection 
was not significantly associated with 
history of blood transfusion, alcohol use, 




 This study represents the results 
of health screening for hepatitis C virus 
infection and HIV in asymptomatic 
Nigerians. The prevalence of HCV in this 
study was low at 0.7%. This is similar to 
findings of 0.4% among University 
under-graduates in Ogbomoso (9), a 
population based screening in Lagos 
0.9% (4), and among first time blood 
donors in Abeokuta 1.5% (10). It is also 
similar to findings in studies from other 
African countries such as Eritrea 0.7%, 
Somalia 0.9% and Sudan 1% (11 – 12). 
However, the prevalence of HCV 
antibody in this study is lower than that 
reported among healthy blood donors in 
Port Harcourt 5%, Calabar 10%, a rural 
population in Cameroon 6.3% and the 
WHO estimated African regional HCV 
prevalence of 5.3% (13 – 16). The 
differences in prevalence across the 
studies may be due to differences in 
demographics, socioeconomic status, 
risk behaviour, and the method of 
testing employed. The low prevalence in 
this study may also be due to the fact 
that the subjects live in Lagos which is 
an urban area, because the prevalence 
of HCV has been reported to be higher in 
rural versus urban areas (17). 
 The prevalence of HIV infection in 
this study was found to be 2%, which is 
similar to studies from Burkina Faso with 
1.8%, and Tanzania 2.2% (18, 19). It is 
lower than the Nigerian national 
prevalence of 2.9% (2), other studies 
from Nigeria such as 3.1% from Osogbo 
(20) and 6.2% from Abeokuta (10), and 
studies from other African countries such 
as Ethiopia 3.8%, and Cameroon 4.1% 
(21–22). The prevalence of 2% is higher 
than the reported rates of 0.3% in 
Eritrea and 1.2% in Mauritania among 
blood donors (11, 23). Differences in 
demographic factors, socioeconomic 
status, level of education and exposure 
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to risk factors may account for these 
differences. 
 Many studies have demonstrated 
co-infection with the hepatitis C virus 
and HIV. However, no co-infection was 
demonstrated in this study, and this is 
similar to other studies from Benin-city 
and Ethiopia (24 – 25). In this study, 
older age was not found to be a risk 
factor for hepatitis C virus infection as it 
has been previously described. Those 
who were 30 years or younger had the 
highest prevalence of HCV antibody but 
age was not statistically significant. 
Males had a higher rate of HCV infection 
in this study but gender was not a 
significant risk factor. Unsafe blood 
supply has contributed to HCV 
transmission in developing countries but 
in this study previous history of blood 
transfusion was not significantly 
associated with risk of HCV infection. 
Marital status, previous history of 
surgery, and alcohol use, were not 
significantly associated with the risks of 
HCV infection. In as many as one third 
of subjects with HCV, a risk factor could 
not be identified for their infection (26 – 
28).     
 In this study, those with no 
previous history of surgery were 5 times 
more likely to be infected with HIV. No 
history of previous history of surgery 
was significantly associated with the risk 
of HIV infection. This is surprising 
because surgical procedures which are 
invasive offer opportunity for 
transmission of HIV through poor 
infection control practices such as use of 
contaminated surgical instruments, 
equipment and injections. It may also be 
due to a cofounding factor. The reason 
for this is not clear. Transfusion of 
infected blood and blood products 
contribute to transmission of HIV 
infection and these products are 
routinely screened for HIV. However, 
prior history of blood transfusion was not 
significantly associated with risk of HIV 
infection in this study.  
 The highest rate of HIV was 
found in subjects younger than 30 years, 
as is reported in other studies however 
age was not significantly associated with 
the risk of HIV infection. Noteworthy is 
our finding that the highest rates of HIV 
occurred in those who had been 
previously married (divorced or 
separated or widowed) even though this 
was not statistically significant. Men 
were 2 times more likely to be HIV 
infected in this study but gender was not 
significantly associated with HIV 
infection in this study. Some studies 
have shown that women have 
significantly higher HIV prevalence rates 
than men across countries and age 
groups (29).    
 In conclusion, this study among 
apparently healthy Nigerians shows that 
prevalence rates of HCV and HIV were 
lower than earlier documented and there 
was no documented HCV-HIV co-
infection. Previous history of surgery 
was the only significant risk factor for 
HIV infection. Screening of healthy 
individuals for HIV and HCV infection is 
very important to determine those who 
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